The Latest Breaking News from Pfizer

Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering process, 

The Covid vaccine programme has been extended further to include children aged five to 11 without underlying health conditions, in a bid to protect against potential future waves of Covid-19

This blog is now closed.

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

Most parents want their children aged 5-11 to be vaccinated and prefer they receive the Pfizer vaccine produced using mRNA technology, a survey has revealed.

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

China’s surprise decision to clear Pfizer Inc.’s coronavirus pill for use offers rare insight into how Beijing may be planning to move beyond the COVID Zero strategy that’s leaving it increasingly isolated.

UK cases down 30% on the previous week, with weekly deaths down 27.2%; 500 French vehicles arrive in Brussels to protest against Covid measures